Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Réponse sérologique après vaccination contre le coronavirus chez les patients atteints de rhumatisme inflammatoire chronique traités par DMARDs : étude de cohorte et revue systématique avec méta-analyse.
Auroux M, Laurent B, Coste B, Massy E, Mercier A, Durieu I, Confavreux CB, Lega JC, Mainbourg S, Coury F. Auroux M, et al. Among authors: massy e. Rev Rhum Ed Fr. 2022 Oct;89(5):435-446. doi: 10.1016/j.rhum.2022.07.002. Epub 2022 Jul 8. Rev Rhum Ed Fr. 2022. PMID: 35821910 Free PMC article. French.
Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma.
Massy E, Rousseau JC, Gueye M, Bonnelye E, Brevet M, Chambard L, Duruisseaux M, Borel O, Roger C, Guelminger R, Pialat JB, Gineyts E, Bouazza L, Millet M, Maury JM, Clézardin P, Girard N, Confavreux CB. Massy E, et al. J Bone Oncol. 2021 Jun 5;29:100364. doi: 10.1016/j.jbo.2021.100364. eCollection 2021 Aug. J Bone Oncol. 2021. PMID: 34150488 Free PMC article.
Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysis.
Auroux M, Laurent B, Coste B, Massy E, Mercier A, Durieu I, Confavreux CB, Lega JC, Mainbourg S, Coury F. Auroux M, et al. Among authors: massy e. Joint Bone Spine. 2022 Oct;89(5):105380. doi: 10.1016/j.jbspin.2022.105380. Epub 2022 Apr 28. Joint Bone Spine. 2022. PMID: 35490940 Free PMC article.
Synergistic effect between denosumab and immune checkpoint inhibitors (ICI)? A retrospective study of 268 patients with ICI and bone metastases.
Mabrut E, Mainbourg S, Peron J, Maillet D, Dalle S, Fontaine Delaruelle C, Grolleau E, Clezardin P, Bonnelye E, Confavreux CB, Massy E. Mabrut E, et al. Among authors: massy e. J Bone Oncol. 2024 Sep 21;48:100634. doi: 10.1016/j.jbo.2024.100634. eCollection 2024 Oct. J Bone Oncol. 2024. PMID: 39381634 Free PMC article.
End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy.
Sesques P, Karlin L, Massy E, Maarek A, Aussedat G, Lazareth A, Golfier C, Bouafia-Sauvy F, Lequeu H, Ghergus D, Safar V, Ferrant E, Bachy E, Ghesquières H, Confavreux CB, Demangel D, Perrial E, Dumontet C. Sesques P, et al. Among authors: massy e. Front Oncol. 2024 Oct 31;14:1436587. doi: 10.3389/fonc.2024.1436587. eCollection 2024. Front Oncol. 2024. PMID: 39544298 Free PMC article.
Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study.
Balandraud N, Texier G, Massy E, Muis-Pistor O, Martin M, Auger I, Guzian MC, Guis S, Pham T, Roudier J. Balandraud N, et al. Among authors: massy e. PLoS One. 2017 Feb 15;12(2):e0171623. doi: 10.1371/journal.pone.0171623. eCollection 2017. PLoS One. 2017. PMID: 28199343 Free PMC article.
23 results